Financials data is unavailable for this security.
View more
Year on year Predictive Oncology Inc grew revenues 18.24% from 1.51m to 1.78m while net income improved from a loss of 25.74m to a smaller loss of 13.98m.
Gross margin | 60.23% |
---|---|
Net profit margin | -802.93% |
Operating margin | -805.63% |
Return on assets | -88.98% |
---|---|
Return on equity | -149.37% |
Return on investment | -121.17% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Predictive Oncology Inc fell by 13.34m. Cash Flow from Financing totalled 148.90k or 8.36% of revenues. In addition the company used 13.19m for operations while cash used for investing totalled 302.37k.
Cash flow per share | -3.18 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.7171 |
---|---|
Tangible book value per share | 0.6753 |
More ▼
Balance sheet in USDView more
Current ratio | 1.49 |
---|---|
Quick ratio | 1.37 |
Total debt/total equity | 0.0676 |
---|---|
Total debt/total capital | 0.0634 |
More ▼